TG Therapeutics targets $890M-$905M 2026 U.S. BRIUMVI net revenue while anticipating subcutaneous Phase III results around year-end

Dow Jones Futures: 3 Nvidia Partners Lead Earnings Movers; CPI Inflation Data Due

Evolv expects $180M-$185M 2026 revenue as it targets over 10,000 deployed units

Pixelworks expects cash operating expenses below $2.5M per quarter in 2026 while adding a new multiyear device certification deal

RideNow signals continued 2026 adjusted EBITDA and free cash flow focus as refinancing nears completion